News

14 May 2025

Stephen Wright, MD, Joins BRC Therapeutics as Development Advisor

25 January 2025

BRC Announces Development and Regulatory Milestone Following Successful Type C CMC Meeting with FDA, Advancing Clinical Development of Multiple Therapeutic Candidates

3 December 2024

BRC-002 receives Orphan Drug Designation from FDA for Complex Regional Pain Syndrome